Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.41 |
| ▸ | GSTK1 | Q9Y2Q3 | 2/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | TET2 | Q6N021 | 3/20 | 0.38 |
| ▸ | KDM4A | O75164 | 2/20 | 0.38 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7705213 | 0.91 | GSTK1 (0.50) | TSHRNFKB1SLC6A2SLC6A4BLM | |
| SCHEMBL11528893 | 0.91 | CYP2D6 (0.60) | TSHRNFKB1SLC6A2SLC6A4BLM | |
| SCHEMBL21628120 | 0.87 | ABCC4 (0.54) | TSHRNFKB1SLC6A2SLC6A4BLM | |
| SCHEMBL2935706 | 0.87 | ABCC4 (0.54) | TSHRNFKB1SLC6A2SLC6A4BLM | |
| SCHEMBL6422160 | 0.87 | ABCC4 (0.54) | TSHRNFKB1SLC6A2SLC6A4BLM | |
| SCHEMBL1733703 | 0.86 | ALDH1A1 (0.46) | TSHRNFKB1SLC6A2SLC6A4BLM | |
| SCHEMBL28226428 | 0.83 | FFAR4 (0.53) | TSHRBLMMEN1CYP2D6CYP2C19 | |
| SCHEMBL7702223 | 0.80 | SLC6A2 (0.54) | TSHRNFKB1SLC6A2SLC6A4BLM | |
| SCHEMBL12498852 | 0.80 | LMNA (0.43) | TSHRNFKB1SLC6A2SLC6A4BLM | |
| SCHEMBL27906416 | 0.79 | HDAC3 (0.46) | TSHRNFKB1SLC6A2SLC6A4BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103038299-A | Composition for use as coating material and adhesive, method for adhesive bonding, and laminated products | RIKEN TECHNOS CORP | 2013-04-10 | — | — | CN | disclosed |
| CN-102985497-A | Coating for flooring materials and flooring material | RIKEN TECHNOS CORP | 2013-03-20 | — | — | CN | disclosed |
| CN-102906202-A | Coating material for formation of hard coats, and molded products | RIKEN TECHNOS CORP | 2013-01-30 | — | — | CN | disclosed |
| CN-1813021-A | Method for producing cycloolefin resin film or sheet | JSR CORP (JP) | 2006-08-02 | — | — | CN | disclosed |
| US-6348623-B2 | (CO)POLYMERS OF 1-ACETOXY-2-METHOXY-3-BUTENE FOR EXAMPLE; CAN COPOLYMERIZE WITH VINYL ACETATE; REACTING ACETOACETOXY FUNCTIONAL POLYMER WITH AMMONIA OR PRIMARY OR SECONDARY AMINES TO FORM ENAMINE FUNCTIONAL POLYMERS; COATINGS | EASTMAN CHEMICAL COMPANY | 2002-02-19 | — | — | US | disclosed |
| US-20010051690-A1 | Polymers of 3-butene esters, their preparation and use | EASTMAN CHEMICAL COMPANY | 2001-12-13 | — | — | US | disclosed |
| US-6228949-B1 | ACETOACETOXY-DERIVATIZED HOMO OR CO-POLY(3,4-EPOXY-1-BUTENE) WHEREBY THE ACETOACETOXY GROUPS HAVE BEEN REACTED WITH AMMONIA, PRIMARY OR SECONDARY AMINE TO FORM ENAMINE FUNCTIONAL GROUPS; HIGH MOLECULAR WEIGHT COATINGS, ADHESIVES | EASTMAN CHEMICAL COMPANY | 2001-05-08 | — | — | US | disclosed |
| CN-1276800-A | Polymers of 3-butenoic esters, process for their preparation and their use | EASTMAN CHEMIAL CO (US) | 2000-12-13 | — | — | CN | disclosed |
| US-6160057-A | Polymers of 3-butene esters, their preparation and use | EASTMAN CHEMICAL COMPANY (US) | 2000-12-12 | — | — | US | disclosed |
| US-6121400-A | FREE-RADICAL POLYMERIZATION PRODUCT; FOR COATING COMPOSITIONS SUCH AS INKS, ADHESIVES, PAINTS, AND FILMS | EASTMAN CHEMICAL COMPANY (US) | 2000-09-19 | — | — | US | disclosed |
| US-6121399-A | Polymers of 3-butene esters, their preparation and use | EASTMAN CHEMICAL COMPANY (US) | 2000-09-19 | — | — | US | disclosed |
| EP-1023340-A1 | POLYMERS OF 3-BUTENE ESTERS, THEIR PREPARATION AND USE | EASTMAN CHEMICAL COMPANY (US) | 2000-08-02 | — | — | EP | disclosed |
| WO-1999020666-A1 | POLYMERS OF 3-BUTENE ESTERS, THEIR PREPARATION AND USE | EASTMAN CHEMICAL COMPANY (US) | 1999-04-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010051690-A1 | Polymers of 3-butene esters, their preparation and use | CCNT1, C1S, H1-3 | TSHR 4644/4885NFKB1 3596/4885SLC6A2 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.